Long‐Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment-Reference-Cited by-同舟云学术

Long‐Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment

Published:2014-07-28 Issue:8 Volume:66 Page:1987-1997
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Alten Rieke¹,Kaine Jeffrey²,Keystone Edward³,Nash Peter⁴,Delaet Ingrid⁵,Genovese Mark C.⁶

Affiliation:

1. Schlosspark‐Klinik, University Medicine BerlinBerlinGermany

2. Sarasota Arthritis Research CenterSarasotaFlorida

3. Mount Sinai HospitalToronto, OntarioCanada

4. University of QueenslandBrisbane, QueenslandAustralia

5. Bristol‐Myers SquibbPrincetonNew Jersey

6. Stanford UniversityPalo AltoCalifornia

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.38687

Reference37 articles.

1. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

2. The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis;Dore RK;Clin Exp Rheumatol,2007

3. Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up

4. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

5. Injection-site burning and stinging in patients with rheumatoid arthritis using injectable biologics

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential mechanisms of rheumatoid arthritis therapy: Focus on macrophage polarization;International Immunopharmacology;2024-12

2. Novel insights into immune checkpoints in psoriasis and atopic dermatitis: From expression and function to treatments;International Immunopharmacology;2024-09

3. Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort;Reumatismo;2024-06-24

4. Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study;Seminars in Arthritis and Rheumatism;2024-02

5. Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis;International Journal of Molecular Sciences;2022-11-11